Skip to main content

Table 1 Summary of the five previously reported primary orbital cases of peripheral T-cell lymphoma, not otherwise specified and our case

From: Orbital T-cell lymphoma in youngest recorded patient – early diagnosis, management, and successful outcome: a case report and review of the literature

Case #

Author

Age (y)

Sex

Initial presentation

IHC markers

Treatment

Outcome

1)

Coupland et al. (1999) [2]

76

M

Subconjunctival masses, right eye. Right anterior orbital mass (by radiology)

CD45, CD3, CD4, CD8

Conjunctival/eyelid – surgical excision

Orbital – local irradiation of 36 Gy

Alive 5 years after treatment

2)

Lee et al. (2006) [3]

61

F

Left eyeball pain.

Headache

T-cell markers, UCHL-1

Refused chemotherapy and radiotherapy

Died in a month

3)

Janatpour et al. (2007) [4]

44

M

Right eye diplopia and retro-orbital pain

CD2, surface CD3, CD45RO, CD43, CD4, CD8, TIA-1 granzyme B

CHOP – eight cycles

Alive with resolved masses 3 years after initial visit and treatment

4)

Chen et al. (2009) [5]

34

F

Right orbital painful mass. Protruding right eye

CD3 and CD2

Radiotherapy

3-month follow up – proptosis and the protruding mass in the right eye failed to achieve satisfactory resolution

5)

Amit et al. (2012) [6]

6

M

Left eye proptosis. Lagophthalmos

CD45, CD45RO, CD3

Radiotherapy Chemotherapy – vincristine and adriamycin

Died within 1.5 months of diagnosis

6)

Present case

3

M

Left lower eyelid swelling and ptosis

CD3, CD4, CD8, and CD43

Chemotherapy

Alive for 12 months after treatment

  1. CHOP Cyclophosphamide, Hydroxyldaunorubicin, Vincristine (Oncovin), Prednisone, M male, F female, IHC immunohistochemical